ask="1.72"
ask_size="3500"
average_daily_volume="1716980"
bid="1.67"
bid_size="100"
book_value="1.98"
change="-0.37"
change_from_200_day_moving_average="-1.95"
change_from_50_day_moving_average="-0.18"
change_from_52_week_high="-6.22"
change_From_52_week_low="0.59"
change_in_percent="-18.14%"
close="1.67"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.28"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.08"
ex_dividend_date="N/A"
float_shares="10213000"
high="1.95"
high_52_weeks="7.89"
last_trade_date="3/13/2017"
last_trade_price="1.67"
last_trade_size="2421"
last_trade_time="4:00pm"
low="1.60"
low_52_weeks="1.08"
market_capitalization="31.15M"
moving_average_200_day="3.62"
moving_average_50_day="1.85"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="6.90"
open="1.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-53.90%"
percent_change_from_50_day_moving_average="-9.79%"
percent_change_from_52_week_high="-78.83%"
percent_change_from_52_week_low="+54.63%"
previous_close="2.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.03"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="0.51"
stock_exchange="NGM"
symbol="CATB"
volume="6177829"
weeks_range_52="1.08 - 7.89"
